{"pub": "dailymail", "url": "https://dailymail.co.uk/health/article-7585097/J-J-agrees-117M-settlement-pelvic-mesh-devices.html", "downloaded_at": "2019-10-18 01:17:37.831675+00:00", "title": "J&J agrees to $117M to settle vaginal mesh lawsuit with 41 states", "language": "en", "text": "Johnson & Johnson has agreed to a $117 million multi-state settlement over allegations it deceptively marketed its pelvic mesh products, which support women's sagging pelvic organs.\n\nOhio's attorney general said an investigation found J&J, the world's biggest health products maker, violated state consumer protection laws by not fully disclosing the devices' risks.\n\nNumerous women who had the once-popular, hammock-like devices implanted claim they caused severe pain, bleeding and infections.\n\nSome three to four million women have gotten vaginal mesh implants, and more than 150,000 develop complications including, for some, piercing their vaginal walls.\n\nThe settlement, which covers 41 states and the District of Columbia, requires the company to fully disclose risks and stop making inaccurate safety claims.\n\nIt comes as J&J is swamped with thousands of lawsuits claiming patients were harmed by products including baby powder, opioid painkillers and prescription drugs, as well as nearly 25,000 women who say the mesh injured them\n\nJ&J said that the settlement doesn't include admission of any misconduct.\n\nFILE - In this July 30, 2013, file photo, large banners hang in an atrium at the headquarters of Johnson & Johnson in New Brunswick, N.J. Johnson & Johnson has agreed to a $117 million multistate settlement over allegations it deceptively marketed its pelvic mesh products, which support women's sagging pelvic organs. (AP Photo/Mel Evans, File)\n\nVaginal mesh is commonly used to treat incontinence and vaginal prolapse.\n\nBut for five percent of the several million women that get the mesh surgically implanted and develop complications, the risks may not be worth the reward.\n\nMany women are left with seething pain, infections that rot their tissue, or even excruciating tears through their vaginal walls.\n\nSome have even reported that their partners were sliced by the sharp metal mesh implants.\n\nJohnson & Johnson tested its mesh implants with just two small studies conducted by the same doctor, with unheard of success rates in 1998.\n\nThere were never any clinical trials for the device, yet the FDA approved it in 2002.\n\nBy 2008, the product was one the market in the US and billed as a safer, cheaper alternative to other incontinence fixes.\n\nBetween three and four million women worldwide now have similar implants (though not all of them are made by J&J) and between 150,000 and 200,000 of them have been left with complications, according to a UCLA study.\n\nFor those women, chronic pain may be inescapable, holes may be born through their vaginas, and infection after infection may plague the tissue after it's been abraded by the sharp metal device.\n\nFor others, the device became dislodged, at which point it could drift into other organs and wreak havoc.\n\nAccording to the multi-state lawsuit, J&J didn't warn of the high incidence rates of these devastating complications.\n\nIn 2011, the Food and Drug Administration (FDA) issued a safety advisory over the devices, triggering a cascade of lawsuits.\n\nBy 2012, J&J had agreed to take the mesh off the market.\n\nThe complications caused by its product and others like it were so severe and so widespread that in April of this year, the FDA called for the sale of all vaginal mesh - then only marketed by two remaining companies, Coloplast and Boston Scientific - to be halted.\n\nBut that was hardly the end of the saga for J&J, which is still wading through tens of thousands of lawsuits over vaginal mesh.\n\nThe $117 million to be paid out to the 41 states will be for not adequately warning of the products' dangers.\n\nThe lawsuit echoes the $8 billion in damages that a Philadelphia court handed down to a man who developed excess breast tissue after taking J&J's antispychotic drug, Risperdal, which, Nicholas Murray claimed did not warn him of this life-altering side effect.\n\nIn the case of the women injured by vaginal mesh, personal injury suits will have to be fought out one by one or as class actions by the women effected, if they are to be reimbursed for their pain and surgeries to reverse the damage.\n\nThis year alone, $120 million, $41 million and $80 million settlements with and judgement against the health care giant have been awarded to women.", "description": "Johnson & Johnson admits no wrongdoing in the settlement, but has agreed to pay $117 million to 41 states in damages. Some 25,000 women are separately suing over vaginal mesh injuries.", "authors": ["Associated Press", "Natalie Rahhal Deputy Health Editor For Dailymail.Com"], "top_image": "https://i.dailymail.co.uk/1s/2019/10/17/18/wire-19851064-1571334776-586_636x382.jpg", "published_at": "2019-10-17"}